UBS AM’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2B | Buy |
2,449,697
+20,966
| +0.9% | +$11.4M | 0.25% | 80 |
|
|
2025
Q4 | $1.41B | Buy |
2,428,731
+13,728
| +0.6% | +$7.76M | 0.3% | 58 |
|
|
2025
Q3 | $1.17B | Sell |
2,415,003
-658,040
| -21% | -$306M | 0.25% | 74 |
|
|
2025
Q2 | $1.25B | Buy |
3,073,043
+322,120
| +12% | +$135M | 0.25% | 79 |
|
|
2025
Q1 | $1.37B | Buy |
2,750,923
+329,974
| +14% | +$179M | 0.35% | 56 |
|
|
2024
Q4 | $1.26B | Buy |
2,420,949
+257,462
| +12% | +$142M | 0.29% | 58 |
|
|
2024
Q3 | $1.34B | Buy |
2,163,487
+19,536
| +0.9% | +$11.6M | 0.34% | 50 |
|
|
2024
Q2 | $1.19B | Buy |
2,143,951
+560,278
| +35% | +$321M | 0.34% | 53 |
|
|
2024
Q1 | $920M | Sell |
1,583,673
-27,796
| -2% | -$15.6M | 0.33% | 59 |
|
|
2023
Q4 | $855M | Sell |
1,611,469
-96,635
| -6% | -$46.8M | 0.34% | 53 |
|
|
2023
Q3 | $865M | Buy |
1,708,104
+58,966
| +4% | +$31.4M | 0.39% | 44 |
|
|
2023
Q2 | $951M | Hold |
1,649,138
| – | – | 0.46% | 36 |
|
|
2023
Q1 | $951M | Sell |
1,649,138
-216,825
| -12% | -$122M | 0.46% | 36 |
|
|
2022
Q4 | $1.03B | Sell |
1,865,963
-3,709
| -0.2% | -$1.97M | 0.54% | 29 |
|
|
2022
Q3 | $948M | Sell |
1,869,672
-257,334
| -12% | -$144M | 0.53% | 29 |
|
|
2022
Q2 | $1.16B | Buy |
2,127,006
+181,476
| +9% | +$99.9M | 0.61% | 25 |
|
|
2022
Q1 | $1.15B | Sell |
1,945,530
-159,067
| -8% | -$91.4M | 0.49% | 33 |
|
|
2021
Q4 | $1.4B | Sell |
2,104,597
-756,885
| -26% | -$473M | 0.54% | 24 |
|
|
2021
Q3 | $1.63B | Buy |
2,861,482
+445,902
| +18% | +$245M | 0.68% | 19 |
|
|
2021
Q2 | $1.22B | Buy |
2,415,580
+140,393
| +6% | +$66.2M | 0.52% | 26 |
|
|
2021
Q1 | $1.04B | Buy |
2,275,187
+45,448
| +2% | +$21.7M | 0.46% | 34 |
|
|
2020
Q4 | $1.04B | Sell |
2,229,739
-617,042
| -22% | -$289M | 0.49% | 32 |
|
|
2020
Q3 | $1.26B | Sell |
2,846,781
-29,034
| -1% | -$12M | 0.68% | 21 |
|
|
2020
Q2 | $1.04B | Sell |
2,875,815
-59,205
| -2% | -$19.8M | 0.64% | 21 |
|
|
2020
Q1 | $832M | Buy |
2,935,020
+173,018
| +6% | +$54.6M | 0.6% | 27 |
|
|
2019
Q4 | $897M | Sell |
2,762,002
-197,109
| -7% | -$59.8M | 0.55% | 30 |
|
|
2019
Q3 | $862M | Buy |
2,959,111
+835,346
| +39% | +$239M | 0.58% | 30 |
|
|
2019
Q2 | $624M | Sell |
2,123,765
-46,291
| -2% | -$12.7M | 0.44% | 39 |
|
|
2019
Q1 | $594M | Buy |
2,170,056
+50,078
| +2% | +$12.5M | 0.44% | 40 |
|
|
2018
Q4 | $474M | Buy |
2,119,978
+26,961
| +1% | +$6.33M | 0.41% | 48 |
|
|
2018
Q3 | $511M | Buy |
2,093,017
+24,301
| +1% | +$5.59M | 0.38% | 49 |
|
|
2018
Q2 | $429M | Buy |
2,068,716
+187,324
| +10% | +$39.8M | 0.33% | 56 |
|
|
2018
Q1 | $388M | Buy |
1,881,392
+100,210
| +6% | +$21M | 0.31% | 67 |
|
|
2017
Q4 | $338M | Buy |
1,781,182
+11,625
| +0.7% | +$2.23M | 0.29% | 69 |
|
|
2017
Q3 | $335M | Sell |
1,769,557
-46,713
| -3% | -$8.46M | 0.31% | 65 |
|
|
2017
Q2 | $317M | Sell |
1,816,270
-26,991
| -1% | -$4.53M | 0.31% | 66 |
|
|
2017
Q1 | $283M | Sell |
1,843,261
-83,067
| -4% | -$12.7M | 0.29% | 75 |
|
|
2016
Q4 | $272M | Sell |
1,926,328
-80,992
| -4% | -$11.9M | 0.3% | 69 |
|
|
2016
Q3 | $319M | Buy |
2,007,320
+372,076
| +23% | +$57.3M | 0.34% | 62 |
|
|
2016
Q2 | $242M | Buy |
1,635,244
+305,607
| +23% | +$45.1M | 0.27% | 79 |
|
|
2016
Q1 | $188M | Sell |
1,329,637
-1,651,881
| -55% | -$221M | 0.22% | 103 |
|
|
2015
Q4 | $423M | Sell |
2,981,518
-311,406
| -9% | -$41.5M | 0.48% | 39 |
|
|
2015
Q3 | $403M | Sell |
3,292,924
-374,371
| -10% | -$48.8M | 0.44% | 43 |
|
|
2015
Q2 | $476M | Buy |
3,667,295
+320,532
| +10% | +$41.8M | 0.46% | 44 |
|
|
2015
Q1 | $450M | Sell |
3,346,763
-179,335
| -5% | -$23.1M | 0.43% | 48 |
|
|
2014
Q4 | $442M | Sell |
3,526,098
-810,048
| -19% | -$98.5M | 0.42% | 49 |
|
|
2014
Q3 | $528M | Sell |
4,336,146
-119,510
| -3% | -$14.5M | 0.52% | 36 |
|
|
2014
Q2 | $526M | Buy |
4,455,656
+1,986,986
| +80% | +$234M | 0.53% | 36 |
|
|
2014
Q1 | $297M | Sell |
2,468,670
-105,240
| -4% | -$12.5M | 0.32% | 70 |
|
|
2013
Q4 | $287M | Sell |
2,573,910
-81,820
| -3% | -$8.14M | 0.33% | 64 |
|
|
2013
Q3 | $245M | Sell |
2,655,730
-32,114
| -1% | -$2.9M | 0.3% | 79 |
|
|
2013
Q2 | $227M | Buy |
+2,687,844
| New | +$224M | 0.29% | 84 |
|
Other funds holding TMO
VCM
UBS AM's TMO Position: Q1 2026 in Review
UBS AM increased its Thermo Fisher Scientific (TMO) stake by 0.86% in Q1 2026, buying an estimated $11.4M and bringing the position to 2,449,697 shares worth $1.2B. The position accounts for 0.25% of the portfolio, ranked #80.
UBS AM first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.63B in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- UBS AM held 2,449,697 shares of Thermo Fisher Scientific worth $1.2B as of Q1 2026.
- UBS AM bought 20,966 Thermo Fisher Scientific shares in Q1 2026, an estimated $11.4M.
- Thermo Fisher Scientific made up 0.25% of UBS AM's portfolio in Q1 2026, its #80 holding.
- UBS AM first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- UBS AM's Thermo Fisher Scientific position peaked at $1.63B in Q3 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.